The mNG-Col1α2 fusion was tested first in HT1080 fibrosarcoma cells, which correctly assemble and quality-control collagens but lack endogenous expression of Col118, enabling mNG-Col1α2 to be evaluated in the absence of competitor Col1 chains. Here, COL1A2 is linked to fibrosarcoma.